Avicanna Inc. v. Garcia et al, codc:1:2018cv02743

Cosmetics, namely, eye shadow, eyeliner, eyebrow pencils, blushing cream, concealing cream, facial powder, tinted facial moisturizer, lip shimmers and lipstick; skin care products, namely, creams, namely, vanishing cream, moisturizing cream, night cream, day cream, eye cream, hand cream, foot cream and cuticle cream; body and facial oils; bath and beauty soaps; moisturizing body lotions; lotions for the face and body; lip balms and glosses; shaving lotions; shaving balms; colognes; all of the foregoing solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;

Cosmetics, namely, eye shadow, eyeliner, eyebrow pencils, blushing cream, concealing cream, facial powder, tinted facial moisturizer, lip shimmers and lipstick, all of the foregoing containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; skin care products, namely, creams, namely, vanishing cream, moisturizing cream, night cream, day cream, eye cream, hand cream, foot cream and cuticle cream, all of the foregoing containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; body and facial oils containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; bath and beauty soaps containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; moisturizing body lotions containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; lotions for the face and body containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; lip balms and glosses containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; shaving lotions containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; shaving balms containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis; colognes containing hemp derivatives with a delta-9 tetrahydrocannabinol [THC] concentration from 0 to less than 0.3 percent on a dry weight basis;

Cosmetics, namely, eye shadow, eyeliner, eyebrow pencils, blushing cream, concealing cream, facial powder, tinted facial moisturizer, lip shimmers and lipstick; skin care products, namely, creams, namely, vanishing cream, moisturizing cream, night cream, day cream, eye cream, hand cream, foot cream and cuticle cream; body and facial oils; bath and beauty soaps; moisturizing body lotions; lotions for the face and body; lip balms and glosses; shaving lotions; shaving balms; colognes;

Transdermal patches for use in the treatment of pain; transdermal patches for use in the treatment of autoimmune diseases for the purpose of providing general health and well-being; Transdermal patches for use in the treatment of neurological conditions and mental health conditions; Topical preparations, namely, analgesic creams and skin lotions; Inhaled pharmaceutical preparations for the treatment of pain; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders for the purpose of general health and well-being; Inhaled pharmaceutical preparations for the treatment of neurological conditions and mental health conditions; Herbal supplements in the form of capsules and tablets for the treatment of pain; herbal supplements in the form of capsules and tablets for general health and well-being;

Transdermal patches for use in the treatment of pain; transdermal patches for use in the treatment of autoimmune diseases for the purpose of providing general health and well-being; Transdermal patches for use in the treatment of neurological conditions and mental health conditions; Topical preparations, namely, analgesic creams and skin lotions; Inhaled pharmaceutical preparations for the treatment of pain; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders for the purpose of general health and well-being; Inhaled pharmaceutical preparations for the treatment of neurological conditions and mental health conditions; Herbal supplements in the form of capsules and tablets for the treatment of pain; herbal supplements in the form of capsules and tablets for general health and well-being;